These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6350478)

  • 1. [Modification of the expressivity of blood group antigens in urothelial bladder tumors. Prognostic value].
    Roth A; Le Cuziat N; Cukier J
    J Urol (Paris); 1983; 89(4):225-31. PubMed ID: 6350478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Distribution of ABH antigens in tumours of the bladder. A retrospective immunofluorescence study (author's transl)].
    Rouger P; Vallancien G; Leclerc JP; Gane P; Salmon C
    Nouv Presse Med; 1982 Feb; 11(6):419-21. PubMed ID: 7038622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood group ABO (H) cell surface antigens in bladder tumours invading the chorion. Prognostic value of their determination by immunofluorescence. Retrospective study of one hundred and twenty-five cases].
    Vacant J; Le Portz B; Augustin I; Hammou JC; Fella C; Délignières S; Maïolini R; Masseyeff R; Abelanet R; Steg A
    Sem Hop; 1982 May; 58(21):1295-300. PubMed ID: 6287585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.
    Juhl BR
    Dan Med Bull; 1994 Feb; 41(1):1-11. PubMed ID: 8187557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunofluorescence study of the distribution of ABH cell surface antigens in bladder tumours (author's transl)].
    Vallancien G; Rouger P; Leclerc JP; Kuss R
    Sem Hop; 1982 May; 58(19):1161-4. PubMed ID: 6285497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of blood group antigens in 30 patients with transitional-cell carcinomas of the bladder].
    Vieillefond A; Quillard J; Meatchi T; Benoit G; Jardin A; Martin E
    Ann Pathol; 1987; 7(1):9-14. PubMed ID: 3620025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of the detection of ABO surface antigens by indirect immunofluorescence technic in transitional tumors of the bladder].
    Borella T; Loro M; Dato I; Merlo F; Giudici M
    Minerva Med; 1986 Sep; 77(34-35):1527-32. PubMed ID: 3531921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of ABH antigens and CEA for the prognosis of urothelial tumors].
    Hofstädter F; Jakse G
    Wien Klin Wochenschr; 1982 Jul; 94(14):366-8. PubMed ID: 7147976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood group antigens in epithelial tumours of the urinary bladder.
    Marek J; Hradec E; Hanus M; Smolová H
    Czech Med; 1988; 11(3):137-45. PubMed ID: 3147171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of the ABO(H) blood group antigens of the urothelial surface in bladder tumors].
    Proca E; Lucan M; Pîslăraşu M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1987; 36(6):401-12. PubMed ID: 2964680
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of blood group A and H-related antigens in normal and neoplastic bladder epithelium: a comparative study using monoclonal antibodies with defined fine specificities.
    Thorpe SJ; Abel P
    Int J Exp Pathol; 1991 Apr; 72(2):129-38. PubMed ID: 1707648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specific erythrocyte adherence reaction: an index of the malignant potentials of noninvasive tumors of the human urothelium].
    Anichkov NM; Anichkova SI
    Vopr Onkol; 1980; 26(8):9-13. PubMed ID: 7415061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The specific erythrocyte adherence method in the study of ABH antigens on normal and neoplastic bladder epithelium].
    Ongaro G; Issi M; Gallo T; Garbeglio A; Ranieri A; Dalla Palma P
    Quad Sclavo Diagn; 1983 Jun; 19(2):242-61. PubMed ID: 6676774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of ABO group antigens in bladder carcinoma.
    Schlesinger D; Stolarczyk J; Błaszczuk J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):171-4. PubMed ID: 2431666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of A, B and H blood-group antigens and carcinoembryonic antigen in human tumours.
    Sarafian V; Popov A; Taskov H
    Zentralbl Pathol; 1993 Nov; 139(4-5):351-4. PubMed ID: 8130167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunofluorescent study of A.B.H. surface antigens, their precursor and the C.E.A. antigen. The prognostic value of their presence or absence in superficial bladder tumours.
    Vacant J; Hammou JC; Fella C; Philippe P; Rouger P
    Prog Clin Biol Res; 1984; 162A():319-22. PubMed ID: 6385027
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inverted type urothelial cell bladder papillomas. Three new cases (author's transl)].
    Bernheim J; Aronheim M; Griffel B
    J Urol (Paris); 1980; 86(1):57-61. PubMed ID: 7391595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of CDC91L1 (PIG-U) in bladder urothelial cell carcinoma: correlation with clinical variables and prognostic significance.
    Shen YJ; Ye DW; Yao XD; Trink B; Zhou XY; Zhang SL; Dai B; Zhang HL; Zhu Y; Guo Z; Wu G; Nagpal J
    BJU Int; 2008 Jan; 101(1):113-9. PubMed ID: 17941920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isoantigens ABH in bladder tumors as an indicator of malignant potential: a combined study with CEA, BMG, Leu-M1 and H-Ag].
    Saegusa M
    Hinyokika Kiyo; 1989 Aug; 35(8):1311-21. PubMed ID: 2683647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.